Evidence map›Paper›PMID 40108568›Full record

Trial reportBMC public health2025

Efficacy of short message service (SMS) intervention on medication adherence and knowledge of stroke prevention among clinic attendees at risk of stroke: a randomized controlled trial.

Daniel Aigbonoga, Boluwatife Adewale, Joshua Igwilo, Victoria Adeyeye, Tobi Olajide, Oluwatosin Olaniran, Abiodun Akintayo, Peter Aremu, Faith Oluwadamilare, Oluwafemi Popoola and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Development of a Health Text Message System to Support Stroke Prevention: A Component of the Love Your Brain Digital Platform.Health expectations : an international journal of public participation in health care and health policy · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Daniel AigbonogaUniversity of Ibadan, Ibadan, Nigeria. aigbonogadaniel@gmail.com.
Boluwatife AdewaleUniversity of Ibadan, Ibadan, Nigeria.
Joshua IgwiloUniversity of Ibadan, Ibadan, Nigeria.
Victoria AdeyeyeUniversity of Ibadan, Ibadan, Nigeria.
Tobi OlajideUniversity of Ibadan, Ibadan, Nigeria.
Oluwatosin OlaniranUniversity of Ibadan, Ibadan, Nigeria.
Abiodun AkintayoUniversity of Ibadan, Ibadan, Nigeria.
Peter AremuUniversity of Ibadan, Ibadan, Nigeria.
Faith OluwadamilareUniversity of Ibadan, Ibadan, Nigeria.
Oluwafemi PopoolaUniversity of Ibadan, Ibadan, Nigeria.
Adesola OgunniyiUniversity of Ibadan, Ibadan, Nigeria.

Funding

Royal Society of Tropical Medicine and Hygiene 23887466
6 · The paper itself

Abstract

backgroundStroke remains a leading cause of long-term disability and mortality worldwide, particularly in low- and middle-income countries where suboptimal management of modifiable risk factors such as hypertension and diabetes mellitus are prevalent. Poor medication adherence, a critical barrier to effective risk management, is widespread in Nigeria, with adherence rates below 50% in patients with chronic illnesses. This study evaluates the efficacy of a 12-week short message service (SMS)-based intervention in improving medication adherence, knowledge, and prevention practices among hypertensive and diabetic patients attending the Medical Outpatient Clinic at the University College Hospital, Ibadan, Nigeria. METHODOLOGY: A single-center randomized controlled trial was conducted with 150 participants aged 18 years and above and had a documented clinical diagnosis of hypertension and/or diabetes mellitus and currently being treated with a prescribed medication. The intervention group received bi-daily SMS reminders on medication adherence, lifestyle modifications, and stroke prevention, alongside standard care. The control group received standard care only. Outcomes assessed included change in medication adherence, knowledge, stroke prevention practices, and quality of life. A p value of 0.05 was used.

resultThe prevalence of hypertension and diabetes were 90.0% and 20.7% respectively; 16 individuals (10.7%) had comorbidity of hypertension and diabetes. There was a 14.7% increase in the proportion of participants with a high medication adherence in the intervention arm whereas the control arm had a 2.7% increase. This 5 times relative increase in proportion was however not statistically significant. The study showed a significant effect of the intervention on participants knowledge of stroke prevention (t = 3.339, p = 0.001). There was no significant impact of the intervention on self-rated health scores (t = 0.132; p = 0.896).

conclusionThe SMS intervention significantly improved stroke prevention knowledge and showed a non-significant trend towards better medication adherence. Baseline motivational and cultural factors likely influenced outcomes, underscoring the need to address behavioral, cultural and economic barriers. This scalable telehealth model warrants further exploration to optimize adherence in resource-limited settings. CLINICAL

trial registrationThis study was registered on the 25th July and approved on 25th of August 2023 by the Pan African Clinical Trials Registry (PACTR) with unique identification number: PACTR202308767234235. The findings from this study are presented in accordance with the Consolidated Standards of Reporting Trials (CONSORT) statement.

Indexed as

Health Knowledge, Attitudes, PracticeMedication AdherenceStrokeText MessagingAdultAgedDiabetes MellitusFemaleHumansHypertensionMaleMiddle AgedNigeriaDiabetes mellitusHypertensionMedication adherenceRandomized controlled trialShort message service (SMS) interventionStroke knowledge

Identifiers

PMID40108568
PMCPMC11924615

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.